【定制基因编辑疗法治愈罕见遗传病患儿】美国费城儿童医院与宾夕法尼亚大学医学团队利用定制的CRISPR基因编辑疗法,成功治愈了一名患有罕见遗传病的儿童。这项研究成果已发表在《新英格兰医学杂志》上,并在美国基因与细胞治疗学会年会上进行了报告。该突破将为治疗目前尚无有效疗法的罕见疾病打开新的大门。

金融界
16 May
美国费城儿童医院与宾夕法尼亚大学医学团队利用定制的CRISPR基因编辑疗法,成功治愈了一名患有罕见遗传病的儿童。这项研究成果已发表在《新英格兰医学杂志》上,并在美国基因与细胞治疗学会年会上进行了报告。该突破将为治疗目前尚无有效疗法的罕见疾病打开新的大门。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10